Friday 6 November 2026
Export AVNT’s income statement to Excel — free account
Avient Corporation
AVNT Basic Materials Specialty Chemicals
Avient Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 0.61% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +31.8%
- Free cash flow
- +101.7%
- Total debt
- −7.34%
Quarter to September 2026, against a year earlier
45.55
0.23
+0.51%
Follow AVNT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
35.10 | 21.10 | 19.87 | 20.39 |
P/S ratio |
0.88 | 1.01 | 1.02 | 1.08 | |
P/FCF ratio |
14.66 | 16.23 | 17.76 | 15.44 | |
P/Operating CF |
17.03 | (96.48) | 36.13 | 30.58 | |
P/B ratio |
1.20 | 1.38 | 1.38 | 1.49 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.31 | 1.47 | 1.45 | 1.48 | |
EV/EBITDA |
10.97 | 9.91 | 9.57 | 9.73 | |
EV/Operating CF |
14.16 | 15.17 | 16.17 | 14.58 | |
EV/FCF |
21.90 | 23.53 | 25.36 | 21.22 | |
Quick Ratio |
1.12 | 1.17 | 1.21 | 1.10 | |
Current Ratio |
1.66 | 1.77 | 1.90 | 1.71 | |
Net Debt/EBITDA |
16.29 | 10.42 | 9.00 | 10.64 | |
Debt/Assets |
31.92% | 32.37% | 31.24% | 30.73% | |
Debt/Equity |
0.81 | 0.80 | 0.77 | 0.74 | |
Asset Turnover |
0.55 | 0.56 | 0.55 | 0.57 | |
Operating CF/Net income |
9.93 | (0.62) | 1.45 | 2.83 | |
Capex/Depreciation |
(0.90) | (0.40) | (0.46) | (0.53) | |
Interest Coverage |
1.74 | 4.35 | 5.04 | 3.64 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.98% | 20.86% | 21.29% | 21.23% | |
Intangible Assets out of Total Assets |
0.54 | 0.54 | 0.53 | 0.53 | |
Share Based Compensation of Revenue |
0.29% | 0.25% | 0.22% | 0.28% | |
Graham Net Nets |
(0.78) | (0.63) | (0.60) | (0.53) | |
Graham Number |
22.85 | 31.94 | 33.44 | 34.60 | |
Earnings Yield |
2.85% | 4.74% | 5.03% | 4.91% | |
Free Cash Flow Yield |
6.82% | 6.16% | 5.63% | 6.48% | |
Revenue per Share |
8.31 | 9.24 | 10.00 | 9.72 | |
Operating CF per Share |
1.83 | (0.38) | 1.02 | 1.32 | |
Capex per Share |
(0.46) | (0.21) | (0.24) | (0.27) | |
Free Cash Flow per Share |
1.37 | (0.58) | 0.78 | 1.04 | |
Cash per Share |
5.58 | 4.66 | 4.64 | 4.86 | |
Shareholders Equity per Share |
26.08 | 26.37 | 26.72 | 26.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
26.08 | 26.37 | 26.72 | 26.94 | |
Free Cash Flow |
125.40 | (53.50) | 71.50 | 95.60 | |
Working Capital |
554.60 | 620.80 | 726.50 | 628.80 | |
Capital Expenditures |
(42.40) | (19.00) | (22.30) | (25.10) | |
Net Current Asset Value |
(2,238.40) | (2,102.90) | (2,021.40) | (1,965.40) | |
EV/EBIT |
20.99 | 16.16 | 15.37 | 15.35 | |
Capex to Sales |
0.06 | 0.02 | 0.02 | 0.03 | |
Price to Operating Income |
14.05 | 11.15 | 10.76 | 11.17 | |
| Other line items | |||||
Average Receivables |
417.25 | 501.50 | 538.45 | 502.60 | |
Average Payables |
413.70 | 424.15 | 457.05 | 416.55 | |
Average Inventory |
357.00 | 379.60 | 415.25 | 417.20 | |
Average Assets |
5,918.35 | 5,878.00 | 6,069.05 | 6,000.60 | |
Average Common Equity |
2,357.95 | 2,366.20 | 2,412.00 | 2,429.55 |
Columns are period end dates · fundamentals updated 6 Nov 2026